The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Canadian Announcement on Merck–Schering-Plough Transaction Closing

Merck closed its merger with Schering-Plough yesterday, following regulatory clearance in China and Mexico.  They held press events yesterday and today, and this morning they appear to have released country-specific announcments.

Here’s the blurb on Canadian operations:

“Canada is an integral part of the company’s expanded global presence. Merck will now market over 530 pharmaceutical, consumer and animal health products, employ over 1800 people, generate over $1.2 billion in pharmaceutical sales and invest over $121 million in research and development in Canada. Merck operations in Canada include research, manufacturing, and sales.”

The Merck Canada website is still being updated.

Bookmark and Share

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 128 other followers